Knockdown of SRSF1 resulted in a decrease in Mcl-1 in the breast cancer cell lines studied and an increase in the choriocarcinoma cells, and achieved this by both affecting protein stability and translation of Mcl-1. This evidence concerns the gene MCL1 and breast cancer.